Literature DB >> 26550608

Magnetic Resonance Imaging and Spectroscopy: Application to Experimental Neuro-Oncology.

Brian D Ross1, Thomas L Chenevert2, Boklye Kim, Oded Ben-Yoseph.   

Abstract

The development and use of animal brain tumor models over the past 25 years has helped to advance our understanding of both tumor biology and the effectiveness of new therapeutic approaches. The application of MRI and MRS as noninvasive tools for in vivo studies of intracerebral tumor models provides unique possibilities for furthering our knowledge of brain cancer. This article provides a brief background of traditional techniques used to evaluate growth and treatment efficacy in rodent brain tumor models and overviews the use of MR for quantitating intracerebral tumor growth kinetics and therapeutic response of experimental brain tumors from work conducted in this laboratory. The application of MRI and MRS in rodent brain tumor models for evaluation of novel therapeutic approaches, including gene transfer technology, is discussed. Finally, initial results with diffusion MRI for monitoring the treatment of brain tumors is introduced.

Entities:  

Keywords:  9L gliosarcoma; glioma; magnetic resonance imaging (MRI); magnetic resonance spectroscopy (MRS); tumor cell kill; tumor growth kinetics

Year:  1994        PMID: 26550608      PMCID: PMC4634890     

Source DB:  PubMed          Journal:  Q Magn Reson Biol Med


  38 in total

1.  Comparison of clonogenic cell assays after in vivo and in vitro treatment of 9L gliosarcoma.

Authors:  M L Rosenblum; D F Deen; T Hoshino; D A Dougherty; M E Williams; C B Wilson
Journal:  Br J Cancer Suppl       Date:  1980-04

2.  Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy.

Authors:  F L Moolten
Journal:  Cancer Res       Date:  1986-10       Impact factor: 12.701

3.  In vivo clonogenic tumor cell kinetics following 1,3-bis(2-chloroethyl)-1-nitrosourea brain tumor therapy.

Authors:  M L Rosenblum; K D Knebel; D A Vasquez; C B Wilson
Journal:  Cancer Res       Date:  1976-10       Impact factor: 12.701

4.  Ascorbic acid enhances the effects of 6-hydroxydopamine and H2O2 on iron-dependent DNA strand breaks and related processes in the neuroblastoma cell line SK-N-SH.

Authors:  G Bruchelt; I U Schraufstätter; D Niethammer; C G Cochrane
Journal:  Cancer Res       Date:  1991-11-15       Impact factor: 12.701

5.  Reversible oxidation of glyceraldehyde 3-phosphate dehydrogenase thiols in human lung carcinoma cells by hydrogen peroxide.

Authors:  A E Brodie; D J Reed
Journal:  Biochem Biophys Res Commun       Date:  1987-10-14       Impact factor: 3.575

6.  Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

Authors:  M D Walker; S B Green; D P Byar; E Alexander; U Batzdorf; W H Brooks; W E Hunt; C S MacCarty; M S Mahaley; J Mealey; G Owens; J Ransohoff; J T Robertson; W R Shapiro; K R Smith; C B Wilson; T A Strike
Journal:  N Engl J Med       Date:  1980-12-04       Impact factor: 91.245

7.  Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir.

Authors:  E H Oldfield; Z Ram; K W Culver; R M Blaese; H L DeVroom; W F Anderson
Journal:  Hum Gene Ther       Date:  1993-02       Impact factor: 5.695

8.  In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors.

Authors:  K W Culver; Z Ram; S Wallbridge; H Ishii; E H Oldfield; R M Blaese
Journal:  Science       Date:  1992-06-12       Impact factor: 47.728

9.  Is cell survival a determinant of the in situ response of 9L tumours?

Authors:  K T Wheeler; C A Wallen
Journal:  Br J Cancer Suppl       Date:  1980-04

10.  Oxidation therapy: the use of a reactive oxygen species-generating enzyme system for tumour treatment.

Authors:  O Ben-Yoseph; B D Ross
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640

View more
  24 in total

1.  Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging.

Authors:  J P Galons; M I Altbach; G D Paine-Murrieta; C W Taylor; R J Gillies
Journal:  Neoplasia       Date:  1999-06       Impact factor: 5.715

2.  The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome.

Authors:  Bradford A Moffat; Thomas L Chenevert; Charles R Meyer; Paul E McKeever; Daniel E Hall; Benjamin A Hoff; Timothy D Johnson; Alnawaz Rehemtulla; Brian D Ross
Journal:  Neoplasia       Date:  2006-04       Impact factor: 5.715

3.  Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance.

Authors:  Victor D Schepkin; Kuei C Lee; Kyle Kuszpit; Mukilan Muthuswami; Timothy D Johnson; Thomas L Chenevert; Alnawaz Rehemtulla; Brian D Ross
Journal:  NMR Biomed       Date:  2006-12       Impact factor: 4.044

Review 4.  Predicting and monitoring cancer treatment response with diffusion-weighted MRI.

Authors:  Harriet C Thoeny; Brian D Ross
Journal:  J Magn Reson Imaging       Date:  2010-07       Impact factor: 4.813

5.  Assessment of multiexponential diffusion features as MRI cancer therapy response metrics.

Authors:  Benjamin A Hoff; Thomas L Chenevert; Mahaveer S Bhojani; Thomas C Kwee; Alnawaz Rehemtulla; Denis Le Bihan; Brian D Ross; Craig J Galbán
Journal:  Magn Reson Med       Date:  2010-09-21       Impact factor: 4.668

6.  Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response.

Authors:  Bradford A Moffat; Thomas L Chenevert; Theodore S Lawrence; Charles R Meyer; Timothy D Johnson; Qian Dong; Christina Tsien; Suresh Mukherji; Douglas J Quint; Stephen S Gebarski; Patricia L Robertson; Larry R Junck; Alnawaz Rehemtulla; Brian D Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-01       Impact factor: 11.205

7.  Advanced MRI: translation from animal to human in brain tumor research.

Authors:  Bradford A Moffat; Craig J Galbán; Alnawaz Rehemtulla
Journal:  Neuroimaging Clin N Am       Date:  2009-11       Impact factor: 2.264

8.  Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck.

Authors:  Daniel A Hamstra; Kuei C Lee; Bradford A Moffat; Thomas L Chenevert; Alnawaz Rehemtulla; Brian D Ross
Journal:  Transl Oncol       Date:  2008-12       Impact factor: 4.243

9.  Voxel-by-voxel functional diffusion mapping for early evaluation of breast cancer treatment.

Authors:  Bing Ma; Charles R Meyer; Martin D Pickles; Thomas L Chenevert; Peyton H Bland; Craig J Galbán; Alnawaz Rehemtulla; Lindsay W Turnbull; Brian D Ross
Journal:  Inf Process Med Imaging       Date:  2009

10.  Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival.

Authors:  Daniel A Hamstra; Craig J Galbán; Charles R Meyer; Timothy D Johnson; Pia C Sundgren; Christina Tsien; Theodore S Lawrence; Larry Junck; David J Ross; Alnawaz Rehemtulla; Brian D Ross; Thomas L Chenevert
Journal:  J Clin Oncol       Date:  2008-06-09       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.